| Literature DB >> 31375263 |
Chang Hoon Ji1, Hee Yeon Kim2, Ah Jung Heo1, Su Hyun Lee1, Min Ju Lee1, Su Bin Kim1, Ganipisetti Srinivasrao2, Su Ran Mun1, Hyunjoo Cha-Molstad3, Aaron Ciechanover4, Cheol Yong Choi5, Hee Gu Lee6, Bo Yeon Kim7, Yong Tae Kwon8.
1. Protein Metabolism Medical Research Center and Department of Biomedical Sciences, College of Medicine, Seoul National University, Seoul 110-799, Republic of Korea.
2. Protein Metabolism Medical Research Center and Department of Biomedical Sciences, College of Medicine, Seoul National University, Seoul 110-799, Republic of Korea; AUTOTAC, Changkkyunggung-ro 254, Jongno-gu, Seoul 110-799, Republic of Korea.
3. World Class Institute, Anticancer Agents Research Center, Korea Research Institute of Bioscience and Biotechnology, Ochang, Cheongwon 28116, Republic of Korea.
4. Protein Metabolism Medical Research Center and Department of Biomedical Sciences, College of Medicine, Seoul National University, Seoul 110-799, Republic of Korea; Technion Integrated Cancer Center, Faculty of Medicine, Technion-Israel Institute of Technology, Haifa 3109601, Israel.
5. Department of Biological Sciences, Sungkyunkwan University, Suwon 440-746, Republic of Korea. Electronic address: choicy@skku.edu.
6. Immunotherapy Convergence Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, Republic of Korea. Electronic address: hglee@kribb.re.kr.
7. World Class Institute, Anticancer Agents Research Center, Korea Research Institute of Bioscience and Biotechnology, Ochang, Cheongwon 28116, Republic of Korea. Electronic address: bykim@kribb.re.kr.
8. Protein Metabolism Medical Research Center and Department of Biomedical Sciences, College of Medicine, Seoul National University, Seoul 110-799, Republic of Korea; Protech, Yongeon 103 Daehangno, Jongno-gu, Seoul 110-799, Republic of Korea; Ischemic/Hypoxic Disease Institute, College of Medicine, Seoul National University, Seoul 110-799, Republic of Korea. Electronic address: yok5@snu.ac.kr.
Abstract
Entities:
Keywords: ER homeostasis; ER protein quality control; ER stress response; ER-phagy; N-degron pathway; N-terminal arginylation; TRIM13; endoplasmic reticulum; p62; ubiquitination; α1-antitrypsin deficiency
Year: 2019 PMID: 31375263 DOI: 10.1016/j.molcel.2019.06.028
Source DB: PubMed Journal: Mol Cell ISSN: 1097-2765 Impact factor: 17.970